or
forgot password
  • cancer clinical trials in jackson, MS

  • S9805, High-Dose Melphalan Plus Peripheral Stem Cell Transplantation Followed by Interferon Alfa in Treating Patients With Waldenstrom's Macroglobulinemia
    University of Mississippi Medical Center

    Trial Locations
    University of Mississippi Medical Center
    Veterans Affairs Medical Center - Jackson
    Lymphoma
    Aminocamptothecin in Treating Patients With Recurrent or Refractory Ovarian Epithelial Cancer or Primary Cancer of the Peritoneum
    University of Mississippi Medical Center
    Jackson, Mississippi 39216-4505
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    506U78 in Treating Patients With Refractory or Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
    University of Mississippi Medical Center

    Trial Locations
    University of Mississippi Medical Center
    Veterans Affairs Medical Center - Jackson
    Leukemia, Lymphoma
    Etoposide Plus Radiation Therapy Followed by Combination Chemotherapy in Treating Children With Newly Diagnosed Advanced Medulloblastoma
    University of Mississippi Medical Center
    Jackson, Mississippi 39216-4505
    Brain and Central Nervous System Tumors
    S9806: Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
    University of Mississippi Medical Center

    Trial Locations
    University of Mississippi Medical Center
    Veterans Affairs Medical Center - Jackson
    Lung Cancer
    Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer
    University of Mississippi Medical Center

    Trial Locations
    University of Mississippi Medical Center
    Veterans Affairs Medical Center - Jackson
    Colorectal Cancer
    Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Newly Diagnosed Brain Stem Glioma
    University of Mississippi Medical Center
    Jackson, Mississippi 39216-4505
    Brain and Central Nervous System Tumors
    High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma
    University of Mississippi Cancer Clinic
    Jackson, Mississippi 39216-4505
    Melanoma (Skin)
    Carboplatin Plus Paclitaxel With or Without Continued Low-Dose Paclitaxel in Treating Patients With Early-Stage Ovarian Cancer
    University of Mississippi Medical Center
    Jackson, Mississippi 39216-4505
    Ovarian Cancer
    Dactinomycin in Treating Patients With Persistent or Recurrent Gestational Trophoblastic Neoplasia
    University of Mississippi Medical Center
    Jackson, Mississippi 39216-4505
    Gestational Trophoblastic Tumor
    Combination Chemotherapy With or Without G-CSF in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
    University of Mississippi Medical Center
    Jackson, Mississippi 39216-4505
    Endometrial Cancer
    S9810: Gemcitabine Plus Cisplatin in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot Be Removed by Surgery
    University of Mississippi Medical Center

    Trial Locations
    University of Mississippi Medical Center
    Veterans Affairs Medical Center - Jackson
    Malignant Mesothelioma
    Fludarabine With or Without Cyclophosphamide in Treating Patients With Chronic Lymphocytic Leukemia
    Veterans Affairs Medical Center - Jackson
    Jackson, Mississippi 39216
    Leukemia
    O6-benzylguanine and Carmustine in Treating Children With Refractory CNS Tumors
    University of Mississippi Medical Center
    Jackson, Mississippi 39216-4505
    Brain and Central Nervous System Tumors
    S9911, Combination Chemotherapy Plus Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma
    University of Mississippi Medical Center

    Trial Locations
    University of Mississippi Medical Center
    Veterans Affairs Medical Center - Jackson
    Lymphoma
    S9809, Ciprofloxacin Compared With Cephalexin in Treating Patients With Bladder Cancer
    Veterans Affairs Medical Center - Jackson
    Jackson, Mississippi 39216
    Bladder Cancer
    S9804: Vinorelbine in Treating Patients With Stage IV Melanoma
    University of Mississippi Medical Center

    Trial Locations
    University of Mississippi Medical Center
    Veterans Affairs Medical Center - Jackson
    Melanoma (Skin)
    S9902 Docetaxel Plus Carboplatin in Treating Patients With Metastatic or Recurrent Head and Neck Cancer
    Veterans Affairs Medical Center - Jackson
    Jackson, Mississippi 39216
    Head and Neck Cancer
    S9903: Whole Brain Radiotherapy Followed By Stereotactic Radiosurgery for Limited Malignant Melanoma Brain Metastases
    University of Mississippi Medical Center

    Trial Locations
    University of Mississippi Medical Center
    Veterans Affairs Medical Center - Jackson
    Melanoma (Skin), Metastatic Cancer
    Docetaxel in Treating Patients With Recurrent or Refractory Ovarian or Primary Peritoneal Cancer
    University of Mississippi Medical Center
    Jackson, Mississippi 39216-4505
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    S9914: Combination Chemotherapy Plus Filgrastim in Untreated Extensive-Stage Small Cell Lung Cancer
    University of Mississippi Medical Center

    Trial Locations
    University of Mississippi Medical Center
    Veterans Affairs Medical Center - Jackson
    Lung Cancer
    S9915 Triacetyluridine, Fluorouracil, and Leucovorin in Treating Patients With Unresectable, Locally Advanced, or Metastatic Cancer of the Esophagus or Stomach
    University of Mississippi Medical Center

    Trial Locations
    University of Mississippi Medical Center
    Veterans Affairs Medical Center - Jackson
    Esophageal Cancer, Gastric Cancer
    Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer
    University of Mississippi Medical Center
    Jackson, Mississippi 39216-4505
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Topotecan in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cancer
    University of Mississippi Medical Center
    Jackson, Mississippi 39216-4505
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Irofulven in Treating Patients With Persistent or Recurrent, Refractory Endometrial Cancer
    University of Mississippi Medical Center
    Jackson, Mississippi 39216-4505
    Endometrial Cancer
    Combination Chemotherapy With or Without Dexrazoxane in Treating Children With Hodgkin's Disease
    University of Mississippi Medical Center
    Jackson, Mississippi 39216-4505
    Cardiac Toxicity, Lymphoma
    Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia
    University of Mississippi Medical Center
    Jackson, Mississippi 39216-4505
    Leukemia
    Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia
    University of Mississippi Medical Center
    Jackson, Mississippi 39216-4505
    Leukemia
    S9926 Temozolomide in Patients With Unresectable/Metastatic Gastrointestinal Stromal Tumors
    University of Mississippi Medical Center

    Trial Locations
    University of Mississippi Medical Center
    Veterans Affairs Medical Center - Jackson
    Gastrointestinal Stromal Tumor
    Chemotherapy in Treating Patients With Sarcoma of the Uterus
    University of Mississippi Medical Center
    Jackson, Mississippi 39216-4505
    Endometrial Cancer, Sarcoma
    S9922 Combination Chemo Plus Filgrastim With or Without Thalidomide in Refractory Multiple Myeloma
    University of Mississippi Medical Center

    Trial Locations
    University of Mississippi Medical Center
    Veterans Affairs Medical Center - Jackson
    Multiple Myeloma
    Liposomal Doxorubicin in Treating Patients With Advanced or Recurrent Endometrial Cancer
    University of Mississippi Medical Center
    Jackson, Mississippi 39216-4505
    Endometrial Cancer
    Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia
    University of Mississippi Medical Center
    Jackson, Mississippi 39216-4505
    Leukemia, Lymphoma
    S0010 506U78 in Treating Patients With Recurrent or Refractory Acute Lymphocytic Leukemia
    University of Mississippi Medical Center

    Trial Locations
    University of Mississippi Medical Center
    Veterans Affairs Medical Center - Jackson
    Leukemia